Expertise in
1
conditions

Maud Aumont

Nantes, FR 
Expertise in
1
conditions
Nantes, FR 

Overview

Maud Aumont practices practicing medicine in Nantes, France.

Ms. Aumont is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Oligodendroglioma, Glioma, Gliomatosis Cerebri, and Glioblastoma.

She is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Nantes, 44300, France
Other Locations
Boulevard Jacques Monod, 44800 St Herblain, Sete, 44800, France
Saint Herblain, France
Rene, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase I Study of Escalated Pharmacologic Dose, of Oral Folinic Acid in Combination With Temozolomide, According to Stupp R. Regimen, in Patients With Operated Grade-IV Astocytoma and a Non-methylated Gene Status of MGMT.
Phase I Study of Escalated Pharmacologic Dose, of Oral Folinic Acid in Combination With Temozolomide, According to Stupp R. Regimen, in Patients With Operated Grade-IV Astocytoma and a Non-methylated Gene Status of MGMT.
Enrollment Status: Terminated
Publish Date: February 21, 2023
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma: Multicentric Prospective Study
Enrollment Status: Terminated
Publish Date: February 09, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

11 Total Publications

The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.
The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.
Journal: Cancers
Published: April 06, 2023

Frequently Asked Questions about Maud Aumont

Is Maud Aumont a top-rated expert for Oligodendroglioma?

MediFind is an objective health platform that identifies experts based on real-world data. Maud Aumont is classified as an Advanced expert for Oligodendroglioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maud Aumont participate in research or clinical trials?

Yes. Maud Aumont has published 11 articles and abstracts on conditions like Oligodendroglioma. You can view a list of Maud Aumont's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Aumont's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile